Taiwan FDA registration d17a68344f65d05c5b2e20bbe7072b80
Bundis Human Immunoglobulin M Set
TW: 邦迪斯人類免疫球蛋白M套組
Taiwan·Risk Class 2·THE BINDING SITE GROUP LIMITED·Registered Nov 05, 2012 – Nov 05, 2027ActiveRegistration details
- Analysis ID
- d17a68344f65d05c5b2e20bbe7072b80
- Customs Code
- DHA00602410901
Company information
- Manufacturer
- THE BINDING SITE GROUP LIMITED
- Manufacturer Country
- United Kingdom
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- Quantitative detection of immunoglobulin M (IgM) in human serum, heparin lithium plasma, or EDTA plasma is required in conjunction with a SPAPLUS analyzer.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5510 免疫球蛋白A,G,M,D及E免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Nov 05, 2012
- Expiry Date
- Nov 05, 2027
About this record
Access comprehensive regulatory information for Bundis Human Immunoglobulin M Set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d17a68344f65d05c5b2e20bbe7072b80 and manufactured by THE BINDING SITE GROUP LIMITED. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices